Safety of sacubitril/valsartan initiated during hospitalization: data from a non‐selected cohort

AIMS: Sacubitril/valsartan is safe when initiated during hospitalization in a clinical trial setting. Its safety in real‐life population is not stablished. We compared the initiation of sacubitril/valsartan during hospitalization in a non‐selected population, in the PIONEER‐HF trial, and in non‐sele...

Descripción completa

Detalles Bibliográficos
Autores principales: López‐Azor, Juan Carlos, Vicent, Lourdes, Valero‐Masa, María Jesús, Esteban‐Fernández, Alberto, Gómez‐Bueno, Manuel, Pérez, Ángel, Díez‐Villanueva, Pablo, De‐Juan, Javier, Manuel‐Iniesta, Ángel, Bover, Ramón, del Prado, Susana, Martínez‐Sellés, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989298/
https://www.ncbi.nlm.nih.gov/pubmed/31701680
http://dx.doi.org/10.1002/ehf2.12527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989298/
https://www.ncbi.nlm.nih.gov/pubmed/31701680
http://dx.doi.org/10.1002/ehf2.12527

Ejemplares similares